These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1862165)
21. Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients. Joober R; Rouleau GA; Lal S; Bloom D; Lalonde P; Labelle A; Benkelfat C Schizophr Res; 2005 Sep; 77(1):35-41. PubMed ID: 16005383 [TBL] [Abstract][Full Text] [Related]
22. Preschizophrenics: adding to the evidence, sharpening the focus. Ambelas A Br J Psychiatry; 1992 Mar; 160():401-4. PubMed ID: 1562869 [No Abstract] [Full Text] [Related]
23. Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Tandon R; Goldman RS; Goodson J; Greden JF Biol Psychiatry; 1990 Jun; 27(12):1323-6. PubMed ID: 2364120 [No Abstract] [Full Text] [Related]
24. Personality disorders among the relatives of schizophrenia patients. Maier W; Lichtermann D; Minges J; Heun R Schizophr Bull; 1994; 20(3):481-93. PubMed ID: 7973465 [TBL] [Abstract][Full Text] [Related]
25. Occupations, factors, and schizophrenia. Muntaner C Schizophr Bull; 1996; 22(1):11-3. PubMed ID: 8685654 [No Abstract] [Full Text] [Related]
26. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients. Hollister LE; Kim DY Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396 [TBL] [Abstract][Full Text] [Related]
27. Childhood antecedents of stable positive symptoms in schizophrenia. Roff JD; Knight RA Psychol Rep; 1995 Aug; 77(1):323-9. PubMed ID: 7501772 [TBL] [Abstract][Full Text] [Related]
28. The risk-benefit ratio of the proposed DSM-5 attenuated psychosis syndrome. Woods SW; McGlashan TH Am J Psychiatry; 2011 Dec; 168(12):1338; author reply 1338. PubMed ID: 22193675 [No Abstract] [Full Text] [Related]
29. The course of DSM-III-R schizophreniform disorder. Sautter F; McDermott B; Garver D J Clin Psychol; 1993 May; 49(3):339-44. PubMed ID: 8315035 [TBL] [Abstract][Full Text] [Related]
30. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760 [TBL] [Abstract][Full Text] [Related]
31. Psychiatric disorders in the families of schizotypal subjects. Battaglia M; Gasperini M; Sciuto G; Scherillo P; Diaferia G; Bellodi L Schizophr Bull; 1991; 17(4):659-68. PubMed ID: 1805355 [TBL] [Abstract][Full Text] [Related]
32. Early treatment events and prediction of response to neuroleptics in schizophrenia. Awad AG; Hogan TP Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):585-8. PubMed ID: 2868492 [TBL] [Abstract][Full Text] [Related]
33. Obsessive-compulsive disorder and schizophrenia in three identical twin pairs. Lewis SW; Chitkara B; Reveley AM Psychol Med; 1991 Feb; 21(1):135-41. PubMed ID: 2047489 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited. Volavka J; Douyon R; Convit A; Czobor P; Cooper TB Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388 [No Abstract] [Full Text] [Related]
36. Toward a better identification and treatment of schizophrenia prodrome. Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056 [TBL] [Abstract][Full Text] [Related]
37. An open trial of buspirone added to neuroleptics in schizophrenic patients. Goff DC; Midha KK; Brotman AW; McCormick S; Waites M; Amico ET J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458 [TBL] [Abstract][Full Text] [Related]